{"cdcTestId":"2013-0421","testcaseName":"#1 @ 9 yrs - 0 days, female, Cervarix ","vaccineGroup":"HPV","evaluationTestType":"Age: At Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2011-05-01T00:00:00","patient":{"dob":"2002-05-01T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2011-05-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2011-10-01T00:00:00","recommendedDate":"2011-11-01T00:00:00","pastDueDate":"2012-06-28T00:00:00"},"doses":[{"dateAdministered":"2011-05-01T00:00:00","vaccineName":"CERVARIX","cvx":"118","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-15T08:35:49.1","generalDescription":"This test case describes when a child is administered the first dose of the HPV vaccine at age 9 years, that another dose should be forecast.","changedInVersion":"3.2","reasonForChange":"Updated to reflect ACIP recommendations for the HPV 2 dose series and to add plus 4 weeks to the latest recommended interval."}